Tag: Sanofi

Texas Lawyer Common Ken Paxton (R) filed a lawsuit accusing Sanofi of offering kickbacks to docs, within the type of ...

The target of AllRock Bio’s research is already validated by FDA-approved medicines — for the eyes. The biotech startup is ...

Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a ...

Novavax’s alliance with Sanofi came at an opportune time for the beleaguered vaccine developer. Its protein-based Covid-19 vaccine never reached ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...

Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the ...

A U.S. government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to ...

Sanofi’s Enjaymo, the only approved drug therapy for a rare and debilitating blood disorder, is being acquired by Recordati in ...

The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended on our ...